Differential pharmacokinetics of liver tropism for iron sucrose, ferric carboxymaltose, and iron isomaltoside: a clue to their safety for dialysis patients

HIGHLIGHTS

• who: Guy Rostoker and collaborators from the Division of Nephrology and Dialysis, Ramsay Santé, Hôpital Privé Claude Galien, Collége de Médecine des Hôpitaux de Paris, Paris, France have published the research: Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients, in the Journal: Pharmaceutics 2022, 1408 of 14/01/2020
• what: The potential beneficial consequences of ferric carboxymaltose and iron isomaltoside on liver structure, with suggested weak accumulation compared with that of iron sucrose, warrant a rigorous demonstration by . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.